Director/PDMR Shareholding
28 May 2020
PZ Cussons Plc (the 'Company')
Notification of Transactions of Persons Discharging Managerial Responsibilities
The Company announces that it received notification today, from Caroline Silver, Non-executive Chair of the Company, that she had purchased 12,500 ordinary shares of 1p each in the Company. The shares were purchased at a price of 175.4p per share on 27 May 2020. Following this dealing, Mrs Silver holds 42,500 shares in the Company representing 0.009% of the shares in issue.
The notification is made in accordance with the requirements of the EU Market Abuse Regulation.
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
a) | Name | Caroline Silver | ||||
2 | Reason for the notification | |||||
a) | Position/status | Non-executive Chair | ||||
b) | Initial notification/Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | PZ Cussons Plc | ||||
b) | LEI | XB3CXKKKED7OMV80FY35 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code |
| ||||
b) | Nature of the transaction | Purchase of shares | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information
| N/A | ||||
e) | Date of the transaction | 2020-05-27 | ||||
f) | Place of the transaction | LONDON STOCK EXCHANGE, MAIN MARKET (XLON) |
Name of contact and telephone number for queries:
Sam Plant
Company Secretary
PZ Cussons Plc
(T) (00) 44 (0)161 435 1000
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.